5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.56▲ | 3.55▲ | 3.57▲ | 3.64▼ | 3.76▼ |
MA10 | 3.59▼ | 3.59▼ | 3.62▼ | 3.73▼ | 4.67▼ |
MA20 | 3.65▼ | 3.63▼ | 3.65▼ | 3.57▲ | 7.15▼ |
MA50 | 3.65▼ | 3.70▼ | 3.72▼ | 4.66▼ | 15.84▼ |
MA100 | 3.70▼ | 3.75▼ | 3.56▲ | 7.61▼ | N/A |
MA200 | 3.74▼ | 3.53▲ | 3.77▼ | 13.50▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.010▼ | -0.009▼ | -0.010▼ | 0.105▲ | 0.105▲ |
RSI | 46.718▼ | 46.051▼ | 46.781▼ | 41.766▼ | 28.139▼ |
STOCH | 22.357 | 17.734▼ | 26.016 | 54.238 | 12.254▼ |
WILL %R | -53.571 | -81.159▼ | -52.830 | -49.524 | -91.534▼ |
CCI | -23.668 | -49.937 | -30.548 | -5.735 | -85.726 |
Tuesday, May 14, 2024 08:59 AM
WESTLAKE VILLAGE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the first ...
|
Monday, May 13, 2024 05:00 PM
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
|
Friday, May 10, 2024 12:53 AM
Genelux (NASDAQ:GNLX) just reported results for the first quarter of 2024.Genelux reported earnings per share of -29 cents. This was below the analyst estimate for EPS of -23 cents.The company ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/05/24 | 3.65 | 3.65 | 3.525 | 3.59 | 40,577 |
15/05/24 | 3.58 | 3.90 | 3.58 | 3.64 | 93,538 |
14/05/24 | 3.71 | 3.96 | 3.34 | 3.58 | 189,693 |
13/05/24 | 3.89 | 3.89 | 3.555 | 3.56 | 62,087 |
10/05/24 | 3.96 | 4.00 | 3.60 | 3.83 | 106,783 |
09/05/24 | 3.78 | 4.025 | 3.67 | 4.02 | 101,378 |
08/05/24 | 3.67 | 3.97 | 3.65 | 3.79 | 113,101 |
07/05/24 | 3.89 | 3.905 | 3.555 | 3.65 | 88,594 |
06/05/24 | 3.95 | 4.11 | 3.78 | 3.84 | 152,759 |
03/05/24 | 3.59 | 3.88 | 3.39 | 3.83 | 124,408 |
|
|
||||
|
|
||||
|
|